APA (7th ed.) Citation

Bird, R. J., Kenealy, M., Forsyth, C., Wellwood, J., Leahy, M. F., Seymour, J. F., & To, L. B. (2012). When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload? Internal Medicine Journal, 42(4), 450. https://doi.org/10.1111/j.1445-5994.2012.02734.x

Chicago Style (17th ed.) Citation

Bird, R. J., M. Kenealy, C. Forsyth, J. Wellwood, M. F. Leahy, J. F. Seymour, and L. B. To. "When Should Iron Chelation Therapy Be Considered in Patients with Myelodysplasia and Other Bone Marrow Failure Syndromes with Iron Overload?" Internal Medicine Journal 42, no. 4 (2012): 450. https://doi.org/10.1111/j.1445-5994.2012.02734.x.

MLA (9th ed.) Citation

Bird, R. J., et al. "When Should Iron Chelation Therapy Be Considered in Patients with Myelodysplasia and Other Bone Marrow Failure Syndromes with Iron Overload?" Internal Medicine Journal, vol. 42, no. 4, 2012, p. 450, https://doi.org/10.1111/j.1445-5994.2012.02734.x.